Company
United StatesPublic company, NYSE: SNNSmith&Nephew Inc. (NYSE: SNN), Phoenix, AZ – FDA Inspections
Inspection records and compliance data for Smith&Nephew Inc. in Phoenix, Arizona. 1 FDA inspection on record, last inspected December 23, 2013. Publicly traded as NYSE: SNN.
Company Profile
This profile covers Smith&Nephew Inc. based in Phoenix, Arizona, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 0
- Warning letters
- 0
Inspected December 23, 2013.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 23, 2013 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 860183 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Smith&Nephew Inc.
Stock ticker
SNN
Exchange
NYSE
Share price
$32.03
Market cap
$13.4B
Price as of
November 6, 2026
FEI Number
3004986091
Address
5017 E Washington St Ste 101, Phoenix, Arizona 85034, United States
Country
United States
ID: 483b17d9-ab8c-4416-afcf-203a0eea16f2